×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Did you mean:
Cerenia
Abionyx hails success of bid to resurrect failed cholesterol drug—without dishing data to back up claims
Fierce Biotech
Abionyx Pharma has hailed the success of a phase 2a clinical trial designed to resurrect a cholesterol drug that first flamed out almost a...
16 months ago
French Biotech fails Second Phase II Trial for Cardiovascular Disease
Labiotech.eu
Cerenis therapeutic's lead candidate CER-001 has failed Phase II for the treatment of patients with post-acute coronary syndrome.
86 months ago
Cerenis Raises €40M in Series C and Wins €10.7M from French Government
Genetic Engineering and Biotechnology News
Cerenis' clinical pipeline also includes CER-627, a fixed-dose combination of niacin and aspirin that is designed to deliver the aspirin dose by...
165 months ago
Following $685 million-plus licensing agreement, Ann Arbor-based Evoq replaces CEO
Crain's Detroit Business
A week after signing a lucrative licensing agreement, the top management at Ann Arbor-based pharmaceutical startup Evoq Therapeutics Inc.
16 months ago
Where are they now? Tracking down 2011's Fierce 15
Fierce Biotech
While the Fierce Biotech team evaluates the most innovative biotechs worthy of the 2021 Fierce 15, it's time to check in with the class of...
32 months ago
Orphazyme A/S: Election of new members of the Board of Directors
Yahoo Life UK
On 16 November 2017, Orphazyme A/S ("Orphazyme") held an extraordinary general meeting at which Anders Hedegaard and Catherine Moukheibir...
78 months ago
Ex-GSK CEO Jean-Pierre Garnier takes up role at Alzheon
PMLiVE
Former GlaxoSmithKline chief executive Jean-Pierre Garnier has been appointed chairman of board of directors at US-based clinical-stage...
101 months ago